Clover Health drops 13% as Q3 revenue misses mark )
syahrir maulana Clover Health Investments (NASDAQ:CLOV) is down 13% in after-hours trading Wednesday after releasing Q3 results that missed on the top line. The bottom line was a beat. The health insurer also boosted its full-year guidance midpoint to target an updated range of adjusted EBITDA profitability of $55M-$65M. In the quarter, the company's net loss narrowed to ~$9.2M compared to ~$41.5M in the year-ago period. Clover Health ended the quarter with restricted and unrestricted cash, cash equivalents, and investments of $531.4M, a 20.9% decline from the end of Q3 2023.
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
